Parker Institute for Cancer Immunotherapy
5 clinical trials · Sponsor
◉ Watch Parker Institute for Cancer Immunotherapy
| Record | Firm | Date |
|---|---|---|
| Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations (NCT03835533) | Parker Institute for Cancer Immunotherapy | 2019-06-21 |
| Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention (NCT03817125) | Parker Institute for Cancer Immunotherapy | 2019-01-28 |
| Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer (NCT03651271) | Parker Institute for Cancer Immunotherapy | 2018-10-17 |
Track Parker Institute for Cancer Immunotherapy automatically
Every clearance here is in the API, with alerts when new ones post.